Betz Cells, also known as giant pyramidal cells, are a specific type of pyramidal neuron found in the primary motor cortex of the brain. These large, multipolar neurons are notable for their long axons that extend to the spinal cord, forming the corticospinal tract. Betz cells play a crucial role in the voluntary control of skeletal muscle movements. They are part of the upper motor neuron system, influencing the activity of lower motor neurons in the spinal cord. The corticospinal tract, originating from Betz cells, is essential for the execution of precise and coordinated voluntary movements. These neurons are characterized by their prominent cell bodies and extensive dendritic arborizations. Betz cells exhibit a high level of excitability and are involved in the initiation and modulation of motor commands. Damage or dysfunction of Betz cells and the corticospinal tract can result in motor deficits, impacting fine motor skills and voluntary movements. Conditions such as stroke or certain neurodegenerative disorders may affect the integrity of the corticospinal tract. Understanding the physiology and connectivity of Betz cells is crucial for unraveling the complexities of motor control and developing therapeutic strategies for conditions involving motor dysfunction, such as motor neuron diseases or injuries to the central nervous system.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy